Literature DB >> 9492814

Vancomycin-resistant Staphylococcus aureus.

R A Howe, K E Bowker, T R Walsh, T G Feest, A P MacGowan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9492814     DOI： 10.1016/S0140-6736(05)78597-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  28 in total

Review 1.  Molecular detection of antimicrobial resistance.

Authors:  A C Fluit; M R Visser; F J Schmitz
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

2.  Methicillin-Resistant Staphylococcus aureus Infections.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

3.  Staphylococcus aureus isolates with reduced susceptibility to glycopeptides belong to accessory gene regulator group I or II.

Authors:  Isabelle Verdier; Marie-Elisabeth Reverdy; Jerome Etienne; Gérard Lina; Michèle Bes; François Vandenesch
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

4.  VISA, hetero-VISA and VRSA: the end of the vancomycin era?

Authors:  John M Conly; B Lynn Johnston
Journal:  Can J Infect Dis       Date:  2002-09

5.  First report of methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Thailand.

Authors:  S Trakulsomboon; S Danchaivijitr; Y Rongrungruang; C Dhiraputra; W Susaemgrat; T Ito; K Hiramatsu
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

6.  Inhibition of the dapE-Encoded N-Succinyl-L,L-diaminopimelic Acid Desuccinylase from Neisseria meningitidis by L-Captopril.

Authors:  Anna Starus; Boguslaw Nocek; Brian Bennett; James A Larrabee; Daniel L Shaw; Wisath Sae-Lee; Marie T Russo; Danuta M Gillner; Magdalena Makowska-Grzyska; Andrzej Joachimiak; Richard C Holz
Journal:  Biochemistry       Date:  2015-08-03       Impact factor: 3.162

7.  Interactions between methicillin and vancomycin in methicillin-resistant Staphylococcus aureus strains displaying different phenotypes of vancomycin susceptibility.

Authors:  R A Howe; M Wootton; P M Bennett; A P MacGowan; T R Walsh
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

Review 8.  Lysine biosynthesis in bacteria: a metallodesuccinylase as a potential antimicrobial target.

Authors:  Danuta M Gillner; Daniel P Becker; Richard C Holz
Journal:  J Biol Inorg Chem       Date:  2012-12-08       Impact factor: 3.358

9.  Synergy of arbekacin-based combinations against vancomycin hetero-intermediate Staphylococcus aureus.

Authors:  Ji Young Lee; Won Sup Oh; Kwan Soo Ko; Sang Taek Heo; Chi Sook Moon; Hyun Kyun Ki; Sungmin Kiem; Kyong Ran Peck; Jae Hoon Song
Journal:  J Korean Med Sci       Date:  2006-04       Impact factor: 2.153

10.  Evaluation of a new Etest vancomycin-teicoplanin strip for detection of glycopeptide-intermediate Staphylococcus aureus (GISA), in particular, heterogeneous GISA.

Authors:  Anne Yusof; Anette Engelhardt; Asa Karlsson; Lina Bylund; Pamela Vidh; Karen Mills; Mandy Wootton; Timothy R Walsh
Journal:  J Clin Microbiol       Date:  2008-07-02       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.